GR3031967T3 - Ocular compositions containing steroids and their use in treating glaucoma - Google Patents

Ocular compositions containing steroids and their use in treating glaucoma

Info

Publication number
GR3031967T3
GR3031967T3 GR990403060T GR990403060T GR3031967T3 GR 3031967 T3 GR3031967 T3 GR 3031967T3 GR 990403060 T GR990403060 T GR 990403060T GR 990403060 T GR990403060 T GR 990403060T GR 3031967 T3 GR3031967 T3 GR 3031967T3
Authority
GR
Greece
Prior art keywords
pct
compositions containing
date
treating glaucoma
containing steroids
Prior art date
Application number
GR990403060T
Other languages
English (en)
Inventor
Gerard Schwadrohn
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9109016A external-priority patent/FR2679138B1/fr
Priority claimed from FR9109017A external-priority patent/FR2679139B1/fr
Priority claimed from FR9109015A external-priority patent/FR2679137B1/fr
Priority claimed from FR9110160A external-priority patent/FR2680108B1/fr
Application filed by Theramex filed Critical Theramex
Publication of GR3031967T3 publication Critical patent/GR3031967T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR990403060T 1991-06-18 1999-11-26 Ocular compositions containing steroids and their use in treating glaucoma GR3031967T3 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
FR9107412 1991-06-18
FR9109016A FR2679138B1 (fr) 1991-07-17 1991-07-17 Compositions pharmaceutiques anti-glaucomateuses et leur procede d'obtention.
FR9109017A FR2679139B1 (fr) 1991-07-17 1991-07-17 Nouvelles compositions pharmaceutiques destinees a l'application oculaire renfermant un derive androstenique et leur procede de preparation.
FR9109015A FR2679137B1 (fr) 1991-07-17 1991-07-17 Nouvelles compositions pharmaceutiques a base d'un derive pregnenique et leur procede de preparation.
FR9110160A FR2680108B1 (fr) 1991-08-09 1991-08-09 Nouvelles compositions pharmaceutiques a base de sterouides 6-hydroxymethyles et leur procede d'obtention.
PCT/FR1992/000549 WO1992022300A1 (fr) 1991-06-18 1992-06-18 Compositions oculaires contenant des steroïdes et leur utilisation pour le traitement du glaucome

Publications (1)

Publication Number Publication Date
GR3031967T3 true GR3031967T3 (en) 2000-03-31

Family

ID=27515565

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990403060T GR3031967T3 (en) 1991-06-18 1999-11-26 Ocular compositions containing steroids and their use in treating glaucoma

Country Status (11)

Country Link
US (1) US5506220A (el)
EP (1) EP0593520B1 (el)
JP (1) JP3328729B2 (el)
KR (1) KR100249555B1 (el)
AT (1) ATE185071T1 (el)
CA (1) CA2111699A1 (el)
DE (1) DE69230069T2 (el)
DK (1) DK0593520T3 (el)
ES (1) ES2139602T3 (el)
GR (1) GR3031967T3 (el)
WO (1) WO1992022300A1 (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004093882A1 (ja) * 2003-04-18 2004-11-04 Advanced Medicine Research Institute 眼に適用する疾患治療剤
EP1621199B8 (en) * 2003-04-18 2011-01-19 Advanced Medicine Research Institute Remedies for diseases to be applied to eye
CN103169714A (zh) * 2005-07-12 2013-06-26 Dmi生物科学公司 治疗疾病的方法和产品
DK2554173T3 (en) * 2009-06-22 2017-01-16 Ampio Pharmaceuticals Inc PROCEDURE FOR DISEASE CARE
BRPI1010086A2 (pt) * 2009-06-22 2018-02-06 Dmi Acquisition Corp método e produtos para tratamento de doenças
CN102134265B (zh) * 2009-12-29 2013-04-03 黄云生 一种合成6-甲基-17α-乙酰氧基-19-去甲孕甾-4,6-二烯-3,20-二酮的方法
CN106983754A (zh) 2011-05-20 2017-07-28 国家医疗保健研究所 Cb1受体拮抗剂
ES2621528T3 (es) 2012-11-28 2017-07-04 INSERM (Institut National de la Santé et de la Recherche Médicale) Derivados de 3-(4’-sustituido)-bencil éter de pregnenolona
EA201500752A1 (ru) 2012-12-19 2016-05-31 Ампио Фармасьютикалс, Инк. Способ лечения заболеваний

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1515284A (en) * 1974-05-21 1978-06-21 Gastaud J Pharmaceutical compositions containing progestogens derived from the 17-alpha-hydroxy-19-nor-progesterone series
US4383992A (en) * 1982-02-08 1983-05-17 Lipari John M Water-soluble steroid compounds
US4617299A (en) * 1983-12-19 1986-10-14 Knepper Paul A Method for the prevention of ocular hypertension, treatment of glaucoma and treatment of ocular hypertension
US4863912A (en) * 1986-05-19 1989-09-05 New York Medical College Use of tetrahydrocortisol in glaucoma therapy
WO1987007141A1 (en) * 1986-05-23 1987-12-03 New England Medical Center Hospitals, Inc. Method for treating glaucoma
FR2622194B1 (fr) * 1987-10-27 1990-03-23 Theramex Laboratoire Nouveaux derives de la 19-nor progesterone, leur procede d'obtention et les compositions pharmaceutiques en contenant
US4876250A (en) * 1988-10-31 1989-10-24 Alcon Laboratories, Inc. Methods for controlling ocular hypertension with angiostatic steroids
FR2645864B1 (fr) * 1989-04-13 1991-07-12 Theramex Nouveaux derives alcoyles en 17/21 de la 19-nor progesterone, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
FR2679236B1 (fr) 1991-07-18 1997-01-24 Theramex Nouveaux sterouides substitues en position 6, leurs procedes d'obtention et des compositions pharmaceutiques en renfermant.

Also Published As

Publication number Publication date
ATE185071T1 (de) 1999-10-15
KR940701260A (ko) 1994-05-28
EP0593520B1 (fr) 1999-09-29
ES2139602T3 (es) 2000-02-16
JP3328729B2 (ja) 2002-09-30
US5506220A (en) 1996-04-09
DK0593520T3 (da) 2000-04-03
JPH06508362A (ja) 1994-09-22
DE69230069T2 (de) 2000-05-25
WO1992022300A1 (fr) 1992-12-23
CA2111699A1 (fr) 1992-12-23
EP0593520A1 (fr) 1994-04-27
KR100249555B1 (ko) 2000-04-01
DE69230069D1 (de) 1999-11-04

Similar Documents

Publication Publication Date Title
CA2084891A1 (en) Methods and formulations for use in inhibiting conception and in treating benign gynecological disorders
CA2162260A1 (en) Methods and formulations for use in treating oophorectomized women
HUT74452A (en) Preparation for substitution therapy, containing at least one progestogen and at least one extrogen
CA2125888A1 (en) Pharmaceutically active antioxidant containing composition and the method of its use to prevent and treat restenosis following angioplasty
HUT73417A (en) Enniatines and enniatine derivatives used to control endoparasites
MY111188A (en) Improvements in or relating to benzothiophenes.
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
GR3033846T3 (en) Imidazopyridines and their use in treating gastrointestinal diseases.
ES2136723T3 (es) Utilizacion de n-aril-metilen-etilen-diamino-triacetatos, n-aril-metilen-imino-diacetatos o n,n'-diaril-metilen-etilen-diamino-acetatos contra el estres oxidante.
GR3024157T3 (en) Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy.
GR3031967T3 (en) Ocular compositions containing steroids and their use in treating glaucoma
MX9504023A (es) Composicion farmaceutica y transdermicamente activa que contiene acido 5-aminolaevulinico y procedimiento para su preparacion.
KR940021064A (ko) 프레그네인 유도체의 사용 방법
GR3034142T3 (en) Composition for the treatment or prevention of herpes
TW248530B (el)
IL111804A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of constipation
GB9015774D0 (en) Novel treatment
GR3025050T3 (en) Etoposide derivatives, process for their preparation, their use as a drug and in the preparation of a drug for treating cancer.
KR910002455A (ko) 아크릴산 유도체를 함유하는 제약 조성물 및 의약으로서 이들의 사용
AU5625194A (en) Rectal flunisolide compositions for treating inflammatory intestinal disorders
AP2001002167A0 (en) Use of 17-ketosteroids for the treatment of toxoplasmosis and crytosporidiosis
UA41376C2 (uk) ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ТА СПОСІБ ЛІКУВАННЯ АНДРОГЕННОЇ АЛОПЕЦІЇ ІНГІБІТОРАМИ 5-<font face="Symbol">a</font>-РЕДУКТАЗИ
MY109207A (en) Subcutaneous implants based on nomegestrol derivatives
MX9701532A (es) Procedimiento para aumentar los niveles de testosterona.